BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3178888)

  • 1. 7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonists.
    Daly JW; Padgett WL; Eger K
    Biochem Pharmacol; 1988 Oct; 37(19):3749-53. PubMed ID: 3178888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
    J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D; Padgett WL; Hong O; Daly JW; Daly DT; Olsson RA
    FEBS Lett; 1987 May; 215(2):203-8. PubMed ID: 3582647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW; Padgett W; Shamim MT; Butts-Lamb P; Waters J
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors.
    Daly JW; Hong O; Padgett WL; Shamim MT; Jacobson KA; Ukena D
    Biochem Pharmacol; 1988 Feb; 37(4):655-64. PubMed ID: 2829919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.
    Jacobson KA; de la Cruz R; Schulick R; Kiriasis L; Padgett W; Pfleiderer W; Kirk KL; Neumeyer JL; Daly JW
    Biochem Pharmacol; 1988 Oct; 37(19):3653-61. PubMed ID: 3178879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
    Ukena D; Shamim MT; Padgett W; Daly JW
    Life Sci; 1986 Aug; 39(8):743-50. PubMed ID: 3016449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW; Padgett WL; Shamim MT
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD; Secunda S; Daly JW; Olsson RA
    J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT; Ukena D; Padgett WL; Daly JW
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships for 2-substituted adenosines at A1 and A2 adenosine receptors.
    Daly JW; Padgett WL; Secunda SI; Thompson RD; Olsson RA
    Pharmacology; 1993; 46(2):91-100. PubMed ID: 8441759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enprofylline on A1 and A2 adenosine receptors.
    Ukena D; Schirren CG; Schwabe U
    Eur J Pharmacol; 1985 Oct; 117(1):25-33. PubMed ID: 3002801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons.
    Ameri A; Jurna I
    Brain Res; 1991 Apr; 546(1):69-78. PubMed ID: 1855150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW; Jacobson KA; Ukena D
    Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase.
    Daly JW; Padgett WL
    Biochem Pharmacol; 1992 Mar; 43(5):1089-93. PubMed ID: 1554381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that propentofylline (HWA 285) influences both adenosine receptors and adenosine transport.
    Fredholm BB; Fastbom J; Kvanta A; Gerwins P; Parkinson F
    Fundam Clin Pharmacol; 1992; 6(3):99-111. PubMed ID: 1628877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes.
    Romano FD; MacDonald SG; Dobson JG
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1088-95. PubMed ID: 2552837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors.
    Ukena D; Olsson RA; Daly JW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):365-76. PubMed ID: 3580959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazodiazepinediones: a new class of adenosine receptor antagonists.
    Daly JW; Hide I; Bridson PK
    J Med Chem; 1990 Oct; 33(10):2818-21. PubMed ID: 2213834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.